Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
6
×
gene therapy
6
×
life sciences
national blog main
national top stories
novartis
6
×
boston blog main
boston top stories
national
new york blog main
new york top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicare
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biogen
cancer
crispr
johnson & johnson
medicaid
merck
pfizer
What
bio
roundup
gene
therapy
biggest
crispr
drug
patients
talk
terms
access
acquisitions
advanced
age
albert
alzheimer’s
approval
becker
bigger
billions
biogen’s
biopharmaceutical
bourla
capacity
car
cell
ceo
come
companies
company
congress
consolidation
convo
deal
democrats
divided
dollars
earlier
eaton
elections
Language
unknown
unset
Current search:
novartis
×
deals
×
" gene therapy "
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel